PT Jayamas Medica Industri Tbk (OMED.JK)
IDR 184.0
(-2.14%)
IDR 184.0
(-2.14%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 336.07 Billion IDR | -23.25% |
| 2022 | 437.89 Billion IDR | -8.95% |
| 2021 | 480.95 Billion IDR | 3.21% |
| 2020 | 466.01 Billion IDR | 97626.82% |
| 2019 | 476.85 Million IDR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 337.02 Billion IDR | 0.28% |
| 2024 Q2 | 408.96 Billion IDR | 21.35% |
| 2023 Q4 | 336.07 Billion IDR | 13.23% |
| 2023 FY | 336.07 Billion IDR | -23.25% |
| 2023 Q2 | 309.1 Billion IDR | -9.53% |
| 2023 Q3 | 296.8 Billion IDR | -3.98% |
| 2023 Q1 | 341.66 Billion IDR | -21.98% |
| 2022 Q4 | 437.89 Billion IDR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| PT Mark Dynamics Indonesia Tbk | 111.44 Billion IDR | -201.55% |
| PT Hetzer Medical Indonesia Tbk | 11.96 Billion IDR | -2707.777% |
| Maja Agung Latexindo Tbk. | 61.38 Billion IDR | -447.469% |